uniQure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade uniQure 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About QURE

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. 

CEO
Matthew C. Kapusta
CEOMatthew C. Kapusta
Employees
209
Employees209
Headquarters
Amsterdam, Noord-Holland
HeadquartersAmsterdam, Noord-Holland
Founded
2012
Founded2012
Employees
209
Employees209

QURE Key Statistics

Market cap
4.17B
Market cap4.17B
Price-Earnings ratio
-17.31
Price-Earnings ratio-17.31
Dividend yield
Dividend yield
Average volume
1.80M
Average volume1.80M
High today
$68.94
High today$68.94
Low today
$66.00
Low today$66.00
Open price
$68.00
Open price$68.00
Volume
890.53K
Volume890.53K
52 Week high
$71.50
52 Week high$71.50
52 Week low
$5.35
52 Week low$5.35

Analyst ratings

92%

of 13 ratings
Buy
92.3%
Hold
7.7%
Sell
0%

People also own

Based on the portfolios of people who own QURE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.